Vaccine for dengue fever passes tests

The world’s first vaccine against dengue fever, being developed by French drugmaker Sanofi, protected against three of the virus’s four strains in a keenly awaited clinical trial in Thailand.

Sanofi said yesterday the proof of efficacy was a key milestone in the quest to develop a dengue shot, adding the results also confirmed the safety of its vaccine.